Endurant Capital Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-281,895
| Closed | -$2.28M | – | 63 |
|
|
2022
Q4 | $2.28M | Buy |
281,895
+15,216
| +6% | +$123K | 0.92% | 23 |
|
|
2022
Q3 | $1.48M | Sell |
266,679
-90,786
| -25% | -$504K | 0.48% | 36 |
|
|
2022
Q2 | $1.86M | Buy |
357,465
+60,957
| +21% | +$318K | 0.65% | 32 |
|
|
2022
Q1 | $2.44M | Buy |
296,508
+184,705
| +165% | +$1.52M | 0.64% | 33 |
|
|
2021
Q4 | $1.66M | Buy |
+111,803
| New | +$1.66M | 0.4% | 44 |
|
|
2021
Q1 | – | Sell |
-172,047
| Closed | -$3.74M | – | 74 |
|
|
2020
Q4 | $3.74M | Sell |
172,047
-290,123
| -63% | -$6.3M | 1.35% | 28 |
|
|
2020
Q3 | $4.65M | Buy |
462,170
+306,165
| +196% | +$3.08M | 1.37% | 20 |
|
|
2020
Q2 | $1.21M | Buy |
+156,005
| New | +$1.21M | 0.07% | 45 |
|
|
2020
Q1 | – | Sell |
-32,666
| Closed | -$359K | – | 66 |
|
|
2019
Q4 | $359K | Buy |
+32,666
| New | +$359K | 0.11% | 47 |
|